Hims & Hers Health, Inc. (HIMS) vs 23andMe Holding Co. (ME)

A side-by-side comparison of Hims & Hers Health, Inc. and 23andMe Holding Co. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of July 30, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total returnHIMS vs ME

growth of $100 · dividends reinvested · last 5y
HIMS +135.7%ME -99.7%HIMS compounded faster
Log scale — wide-divergence pair
01101001kStart $100202120222023202420252026$236$0
HIMS ME

HIMS vs ME: by the numbers

  • HIMS is the larger company ($5.47B vs $15M market cap).
  • Both run net losses; HIMS's is the smaller (-0.56% vs -134.54% net margin).
  • HIMS grew revenue faster over the past five years (69.19% vs -9.07% CAGR).

Metrics side by side

Valuation

MetricHIMSME
P/S ratio2.410.10
P/B ratio12.800.51
EV / EBITDA66.57N/A
FCF yield1.33%N/A

Profitability

MetricHIMSME
Gross margin67.64%53.33%
Operating margin1.32%-126.72%
Net margin-0.56%-134.54%
ROE-2.97%-721.75%
ROIC6.02%-553.10%

Growth (annualized)

MetricHIMSME
Revenue CAGR (5Y)69.19%-9.07%
Total return CAGR (5Y)25.82%-68.93%

Frequently asked

Which has grown faster, HIMS or ME?
Over the past five years, HIMS grew revenue faster — HIMS at a 69.19% CAGR versus ME at -9.07%.
How have HIMS and ME total returns compared?
Over the past 5 years, HIMS delivered 25.82% and ME delivered -68.93% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified July 30, 2026.